Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Young Adult Oncology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00705887
What this trial is testing

A Motivational Enhancement Approach to Skin Cancer Prevention

Who this might be right for
Ultraviolet RaysMotivation
Oregon Health and Science University 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT03793478
What this trial is testing

Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood

Who this might be right for
Acute Myeloid Leukemia
Daiichi Sankyo 65
Not applicableStudy completedNCT06072833
What this trial is testing

Characterizing and Addressing Financial Toxicity in AYAs With Cancer

Who this might be right for
Cancer in Adolescence
Columbia University 26
Not applicableUnknownNCT04265638
What this trial is testing

Exercise Intervention in Adolescent and Young Adult Cancer Survivors

Who this might be right for
Long-term Effects Secondary to Cancer Therapy in AdultsPediatric Cancer
Indiana University 66
Testing effectiveness (Phase 2)Study completedNCT00005793
What this trial is testing

A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide

Who this might be right for
Leukemia
H. Lee Moffitt Cancer Center and Research Institute 41
Early research (Phase 1)Study completedNCT03615404
What this trial is testing

Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma

Who this might be right for
GlioblastomaMalignant GliomaMedulloblastoma Recurrent+3 more
Gary Archer Ph.D. 11
Not applicableTemporarily pausedNCT06639958
What this trial is testing

Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home

Who this might be right for
Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia
Children's Oncology Group 64
Testing effectiveness (Phase 2)UnknownNCT02098512
What this trial is testing

Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients

Who this might be right for
Hodgkin Lymphoma
New York Medical College 20
Testing effectiveness (Phase 2)Looking for participantsNCT07424092
What this trial is testing

Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors

Who this might be right for
High Grade GliomaEpendymomaEmbryonal Tumor of Brain+4 more
Clinica Universidad de Navarra, Universidad de Navarra 39
Not applicableActive Not RecruitingNCT04328350
What this trial is testing

Social Experiences of Adolescents and Young Adults With Cancer

Who this might be right for
Childhood CancerSocial BehaviorSocial Competence
St. Jude Children's Research Hospital 121
Not applicableLooking for participantsNCT07246213
What this trial is testing

CAYA Cancer Retrospective Cohort Study

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic LymphomaYoung Adult Cancer+4 more
Resonance, Inc. 18,000
Not applicableActive Not RecruitingNCT07454460
What this trial is testing

AYA-PeerConnect: A Communication Coaching Intervention for Adolescent/Young Adult Cancer Survivors (AYACS)

Who this might be right for
CommunicationAnxietyDepression+1 more
Milton S. Hershey Medical Center 10
Testing effectiveness (Phase 2)WithdrawnNCT04156659
What this trial is testing

Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
Not applicableNot Yet RecruitingNCT07529080
What this trial is testing

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

Who this might be right for
Differentiated Thyroid Gland CarcinomaMalignant Testicular NeoplasmMelanoma+2 more
University of Michigan Rogel Cancer Center 142
Testing effectiveness (Phase 2)Study completedNCT00546078
What this trial is testing

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 116
Early research (Phase 1)Active Not RecruitingNCT05610891
What this trial is testing

Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG

Who this might be right for
High-Grade Glioma
Cellectar Biosciences, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00231413
What this trial is testing

Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 383
Not applicableStudy completedNCT04248959
What this trial is testing

Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas

Who this might be right for
Sarcoma,Soft TissueOsteosarcoma
University Health Network, Toronto 7
Testing effectiveness (Phase 2)WithdrawnNCT06395090
What this trial is testing

Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01)

Who this might be right for
Neoplasm Metastasis
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Looking for participantsNCT05180825
What this trial is testing

Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy

Who this might be right for
Grade 1 GliomaMixed Glio-neuronal TumorsPleomorphic Xanthoastrocytoma
University Hospital, Strasbourg, France 134
Next Page